Trial Details

TERMINATED
Basic Information
Clinical ID c3897
Identifier NCT01358708
Trial Title Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mg
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Diarrhea-predominant Irritable Bowel Syndrome
Interventions DRUG: LACTEOL® 340 mg|DRUG: PLACEBO
Participant Information
Sponsor Forest Laboratories
City Bordeaux
Country/Region France
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2010-06
Primary Completion Date 2011-09
Completion Date 2011-09